Komori
ReproCELL (4978) · RiskRestated

Impact of Patent Infringement and Infringement of the Company's Patents on Technological Advantage and Business Performance

First written in FY2017. 4 of 5 entries say "Restated". Latest entry: FY2026.

5entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017 – FY20262017: 120172018: 120182019: 020192020: 120202021: 120212022: 020222023: 020232024: 020242025: 020252026: 12026
Same theme, other companies
Third-Party and Own Intellectual Property Rights Infringement RiskA theme 365 companies write about · 366 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2025: 9 of 59 companies on the "Worse" side.

127 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 366 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「Our group promptly files patent applications and takes other measures as necessary with respect to the results of its research and development. Conversely, we cannot rule out the risk that our group may infringe the patents of other companies. Accordingly, we gather information as necessary by using various databases and patent firms and take measures to reduce the risk of patent infringement as far as possible.」

    The company has reaffirmed its measures to protect its patents and avoid infringing other companies’ patents through patent applications and the use of databases and patent firms.
  2. FY2021RestatedAnnual report

    「There is a risk that the patents of our group may be infringed by other companies. Accordingly, our group promptly files patent applications and takes other measures as necessary with respect to the results of its research and development.」

    The company has reaffirmed its measures to protect its patents and avoid infringing other companies’ patents through patent applications and the use of databases and patent firms.
  3. FY2020RestatedAnnual report

    「Our group promptly files patent applications and takes other measures as necessary with respect to the results of its research and development. Conversely, we cannot rule out the risk that our group may infringe the patents of other companies. Accordingly, we gather information as necessary by using various databases and patent firms and take measures to reduce the risk of patent infringement as far as possible.」

    The company has reaffirmed its measures to protect its patents and avoid infringing other companies’ patents through patent applications and the use of databases and patent firms.
  4. FY2018RestatedAnnual report

    「There is a risk that the patents of our group may be infringed by other companies. Conversely, we cannot rule out the risk that our group may infringe the patents of other companies. Accordingly, we gather information as necessary by using various databases and patent firms and take measures to reduce the risk of patent infringement as far as possible.」

    The company described both infringement of its own patents and infringement of other companies’ patents as risks, and reaffirmed its response through patent applications and investigations.
  5. FY2017First statedAnnual report

    「There is a risk that the patents of our group may be infringed by other companies. Conversely, we cannot rule out the risk that our group may infringe the patents of other companies. Accordingly, we gather information as necessary by using various databases and patent firms and take measures to reduce the risk of patent infringement as far as possible.」

    The company stated that infringement of its patents and infringement of other companies’ patents could reduce its technological advantage and result in claims for damages.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for ReproCELL yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impact of Patent Infringement and Infringement of the Company's Patents on Technological Advantage and Business Performance | ReproCELL Incorporated (4978) | Komori